Phillip Eric Lee
Vermögen: 382 129 $ am 30.06.2026
Vermögen: 382 129 $ am 30.06.2026
Phillip Eric Lee formerly worked at Cytokinetics, Inc., as Senior Director from 2015 to 2018, Adverum Biotechnologies, Inc., as Associate Director from 2015 to 2016, 4D Molecular Therapeutics, Inc., as Senior Director & Vice President from 2018 to 2021, Vaxart, Inc., as Chief Financial & Accounting Officer from 2022 to 2025, Centerview Partners LLC, as Principal from 2009 to 2015, and Clover Biopharmaceuticals Ltd., as Chief Financial & Business Development Officer.
Mr. Lee received his undergraduate degree from the University of California, Berkeley.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC. 0,26 % | 24.03.2025 | 631.619 ( 0,26 % ) | 382 129 $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| VAXART, INC. | Finanzdirektor/CFO | 19.05.2025 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Finanzdirektor/CFO | 01.07.2022 |
| 4D MOLECULAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
| CYTOKINETICS, INCORPORATED | Direktor/Vorstandsmitglied | 01.03.2018 |
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 01.01.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centerview Partners LLC
Centerview Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen